Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-26T06:34:46.957Z Has data issue: false hasContentIssue false

The effect of some antiseptic reagents on the bacterial flora of smallpox lymph

Published online by Cambridge University Press:  15 May 2009

Eugene Cardone
Affiliation:
Bureau of Laboratories, New York City Department of Health, Foot of East 16th Street, New York 9, New York
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Data are presented which amplify previously published work on the additive antiseptic effect of Roccal as follows:

1. Smallpox calf pulp derived from animals whose skin is treated with Roccal during the viral incubation period apparently adsorbs sufficient concentration of the reagent to produce a measurable bactericidal effect.

2. The adsorbed antiseptic induces a significant additive effect well beyond that of the action of stated concentrations of phenol and ether alone, as evidenced by the fact that this combination produces rapid diminution of the bacterial flora in highly contaminated calf lymph.

3. Vaccines containing the combination of antiseptics described caused no dermatitis or other untoward reactions in rabbits and humans and their viral potency was not affected.

4. The use of the antiseptic reagents makes possible the rapid preparation of smallpox vaccines for human use. Acceptable bacterial flora levels are obtained usually within 24 hr. of preparation.

The author is indebted to Magda Gagliardi, Marie Mazzochi and Izola Prunty for their assistance in the performance of the many bacterial counts, toxicity tests and other technical work.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1963

References

Cardone, E. (1953). The stability of the viral potency of smallpox vaccine when prepared in calf globulin, dehydrated, and stored without refrigeration. J. Lab. clin. Med. 42, 693–9.Google ScholarPubMed
Cardone, E. (1956). The stability of the viral potency of smallpox vaccine when prepared in the globulin and other protein fractions of calf plasma, dehydrated, and stored at tropical temperatures. J. Lab. clin. Med. 48, 117–23.Google ScholarPubMed
Cardone, E. & Mazzarella, R. (1938). The adsorption of phenol by protein in preparation of certain biologic products. J. Lab. clin. Med. 24, 137–41.Google Scholar
U.S. Departments of Health, Education and Welfare, Public Health Service National Institutes of Health, Bethesda 14, Maryland (1 January 1951). Minimum Requirements: Smallpox Vaccine, 3rd Revision.Google Scholar
Walter, C. W. (1938). The use of a mixture of coconut oil derivatives as a bactericide in the operating room. Surg. Gynec. Obst. 67, 683–8.Google Scholar